AzTrials
AzTrials

Chronic Kidney FailurePhase 1YoDDANCT01671228

Developing and Evaluating the Yorkshire Dialysis Decision Aid

A Phase 1 study testing Decision Aid, Decision aid + patient stories and Decision Aid + values task in people with Chronic Kidney Failure, run by University of Leeds at 6 sites in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this research is to develop a patient decision aid in paper and web formats to help patients with chronic kidney disease make informed dialysis treatment decisions. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Kidney Failure
What is being tested?
Decision Aid, Decision aid + patient stories and Decision Aid + values task
Could I receive a placebo?
No, everyone receives an active treatment
How many people
488 participants
Where
6 sitesUnited Kingdom
Study dates
Jan 2011to Mar 2014
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

None listed.

Who cannot join

  • -

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

United Kingdom6 sites
  • Bradford Teaching Hospital

    Bradford, Yorkshire, BD5 0NA

  • Doncaster Royal Infirmary

    Doncaster, DN2 5LT

  • Hull and East Yorkshire Hospital Trust

    Hull, East Yorkshire, HU3 2JZ

  • St James University Hospital

    Leeds, West Yorkshire, LS97TF

  • Sheffield Northern General Teaching Hospital

    Sheffield, South Yorkshire, S57AU

  • York teaching Hospital NHS Foundation trust

    York, Yorkshire, YO31 8HE

Other trials in United Kingdom

About this study

Official title: Development of a Patient Decision Aid (PtDA) to Facilitate Renal Patients Informed Decisions About Dialysis Treatments

The purpose of this research is to develop a patient decision aid in paper and web formats to help patients with chronic kidney disease make informed dialysis treatment decisions.

Read the detailed description

This research will develop and evaluate a paper and web resource known as a decision-aid to help patients make informed decisions about dialysis treatment. The Yorkshire Dialysis Decision Aid (YoDDA) will help patients' with chronic kidney disease make informed decisions between haemodialysis and peritoneal dialysis choices by a) re-writing dialysis information in a more meaningful way for patients, b) restructuring information to make this difficult decision more manageable, and c) using prompts to help patients imagine the choices' consequences. The research will assess the acceptability of a patient decision aid in paper and web versions to patients and their carers, and its impact on patients choices about dialysis.

The programme of research included:

A survey using qualitative methods of patients with chronic kidney disease and professionals providing predialysis services to develop the Yorkshire Dialysis Decision Aid content, and integration within usual predialysis care practices.

A before-and-after study was carried out to evaluate the acceptability of the YoDDA-booklet to patients with sustained deterioration of kidney function making dialysis decision across the Yorkshire and Humber region, UK.

An experimental study was carried out on-line to evaluate the acceptability of three versions of YoDDA-web (YoDDA; YoDDA+values tasks; YoDDA_patient videos) to people, or carers of people, with kidney disease. The study was advertised with flyers within UK renal units and notices on the National Kidney Federation's website and members' magazine.

Being tested
Decision Aid, Decision aid + patient stories, Decision Aid + values task
Keywords
dialysis, chronic kidney failure, informed choice, patient decision making, decision aid
Medical subject headings
Kidney Failure, Chronic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Decision AidOther

    The Yorkshire Dialysis Decision Aid (YoDDA) resource in web and paper format

  • Decision aid + patient storiesOther

    The Yorkshire dialysis decision aid (YoDDA) plus a set of narratives provided by patients on the treatment options (home and hospital haemodialysis; continuous ambulatory and automated peritoneal dialysis

  • Decision Aid + values taskOther

    The Yorkshire Dialysis decision aid (YoDDA) plus a set of questions to help patients explore what aspects of their life important to them about this decision (values clarification)

Study groups in NCT01671228
Study groupRoleWhat they receive
decision aidExperimentalThe Yorkshire Dialysis Decision Aid (YoDDA). Delivered as a leaflet in clinic and a web resource outside the NHS.
Receives: Other: Decision Aid
Decision Aid + values taskExperimentalThe Yorkshire Dialysis Decision Aid (YoDDA) + values clarification questions. delivered as a leaflet in clinic and a web-based resource outside the NHS.
Receives: Other: Decision Aid; Other: Decision Aid + values task
Decision Aid + patient storiesExperimentalThe Yorkshire Dialysis Decision Aid (YoDDA) + patient stories. Delivered as an web-based resource outside the NHS.
Receives: Other: Decision Aid; Other: Decision aid + patient stories
usual predialysis educationNo interventionThe consultations and information usually provided by the predialysis health professionals

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Preparation for decision making scale

    Assesses patient's perception of how useful the resource was in helping patients prepare for a consultation to talk about their health decision (Graham and O'Connor, 2010). http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_PrepDM.pdf

    Measured: one and six weeks after provision information about dialysis choices

Secondary outcomes (1)
  1. Usefulness of information

    Study specific items to assess perceived usefulness of information in helping patients understand chronic kidney disease, dialysis treatments and thinking about dialysis

    Measured: one and six weeks after the provision of information

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Aug 2012 (estimated)
  2. Study startJan 2011
  3. Primary completionMar 2014
  4. Study completionMar 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
488 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01671228
Sponsor's protocol ID
V4_01_JUN_12
Other IDs
SP2/Choices/2012, 0171-1
Acronym
YoDDA
Status last verified
Apr 2014
First submitted
16 Aug 2012
Last updated
1 May 2014
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Decision Aid, Decision aid + patient stories and Decision Aid + values task in people with Chronic Kidney Failure, run by University of Leeds at 6 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 May 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Preparation for decision making scale (time frame: one and six weeks after provision information about dialysis choices). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in